Browse
We’re here to help

Find guidance on Author Services

Login | Register

Login
Register

Cart Add to Cart

Search
Browse
We’re here to help

Find guidance on Author Services

Home
All Journals
Expert Opinion on Investigational Drugs
List of Issues
Volume 21, Issue 10

Expert Opinion on Investigational Drugs

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Register a free Taylor & Francis Online account today to boost your research and gain these benefits:

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Register now or learn more

Expert Opinion on Investigational Drugs, Volume 21, Issue 10 (2012)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Investigational Drugs, Volume 21, Issue 10 (2012)

See all volumes and issues

Vol 33, 2024 Vol 32, 2023 Vol 31, 2022 Vol 30, 2021 Vol 29, 2020 Vol 28, 2019 Vol 27, 2018 Vol 26, 2017 Vol 25, 2016 Vol 24, 2015 Vol 23, 2014 Vol 22, 2013 Volume 21, 2012 Vol 20, 2011 Vol 19, 2010 Vol 18, 2009 Vol 17, 2008 Vol 16, 2007 Vol 15, 2006 Vol 14, 2005 Vol 13, 2004 Vol 12, 2003 Vol 11, 2002 Vol 10, 2001 Vol 9, 2000 Vol 8, 1999 Vol 7, 1998 Vol 6, 1997 Vol 5, 1996 Vol 4, 1995 Vol 3, 1994

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Research Article

Article

Editorial

Sorafenib for lung cancer: is the “Battle” still open?

Emilio Bria MD, Sara Pilotto MD & Giampaolo Tortora MD PhD

Pages: 1445-1448

Published online: 16 Jul 2012

AbstractforSorafenib for lung cancer: is the “Battle” still open? | Full Text | References | PDF (169.3 KB)

779 Views
3 CrossRef citations
0Altmetric

Free Access

Discontinued Drugs Perspective

Article

Discontinued drugs in 2011: cardiovascular drugs

Hong-Ping Zhao, Hong-Min Jiang & Bing-Ren Xiang

Pages: 1449-1462

Published online: 25 Jul 2012

AbstractforDiscontinued drugs in 2011: cardiovascular drugs | Full Text | References | PDF (414.2 KB)

336 Views
5 CrossRef citations
0Altmetric

Reviews

Review Article

Insulin and GLP-1 analog combinations in type 2 diabetes mellitus: a critical review

Johan Jendle, Sherry A Martin & Zvonko Milicevic MD PhD

Pages: 1463-1474

Published online: 16 Jul 2012

AbstractforInsulin and GLP-1 analog combinations in type 2 diabetes mellitus: a critical review | Full Text | References | PDF (282.8 KB)

1237 Views
11 CrossRef citations
0Altmetric

Review Article

Role of microRNAs in gliomagenesis: targeting miRNAs in glioblastoma multiforme therapy

Alexandra Nikaki, Christina Piperi & Athanasios G Papavassiliou

Pages: 1475-1488

Published online: 19 Jul 2012

AbstractforRole of microRNAs in gliomagenesis: targeting miRNAs in glioblastoma multiforme therapy | Full Text | References | PDF (371.4 KB)

488 Views
63 CrossRef citations
0Altmetric

Review Article

An update on bronchodilators in Phase I and II clinical trials

Mario Cazzola, Paola Rogliani, Andrea Segreti & Maria Gabriella Matera

Pages: 1489-1501

Published online: 23 Aug 2012

AbstractforAn update on bronchodilators in Phase I and II clinical trials | Full Text | References | PDF (247.9 KB)

567 Views
32 CrossRef citations
0Altmetric

Review Article

Role of melatonin in mood disorders and the antidepressant effects of agomelatine

Venkataramanujam Srinivasan, Domenico De Berardis, Samuel D Shillcutt & Amnon Brzezinski

Pages: 1503-1522

Published online: 09 Aug 2012

AbstractforRole of melatonin in mood disorders and the antidepressant effects of agomelatine | Full Text | References | PDF (326.2 KB)

909 Views
59 CrossRef citations
0Altmetric

Review Article

Sclerostin monoclonal antibodies on bone metabolism and fracture healing

Zakareya Gamie, Nectarios Korres, Andreas Leonidou, Andrew C Gray & Eleftherios Tsiridis

Pages: 1523-1534

Published online: 31 Jul 2012

AbstractforSclerostin monoclonal antibodies on bone metabolism and fracture healing | Full Text | References | PDF (215.6 KB)

487 Views
15 CrossRef citations
0Altmetric

Review Article

The role of heat shock protein 90 in modulating ischemia–reperfusion injury in the kidney

Stephen O'Neill MB BCh BAO MSc (dist) MRCSEd, James A Ross PhD, Stephen J Wigmore BSc MBBS MD FRCSEd FRCS & Ewen M Harrison MB ChB PhD FRCS (Gen Surg)

Pages: 1535-1548

Published online: 09 Aug 2012

AbstractforThe role of heat shock protein 90 in modulating ischemia–reperfusion injury in the kidney | Full Text | References | PDF (375.2 KB)

397 Views
28 CrossRef citations
0Altmetric

Drug Evaluations

Article

Therapeutic potential of TDT 067 (terbinafine in Transfersome®): a carrier-based dosage form of terbinafine for onychomycosis

Bárdur Sigurgeirsson & Mahmoud Ghannoum

Pages: 1549-1562

Published online: 09 Aug 2012

AbstractforTherapeutic potential of TDT 067 (terbinafine in Transfersome®): a carrier-based dosage form of terbinafine for onychomycosis | Full Text | References | PDF (441.9 KB)

253 Views
25 CrossRef citations
0Altmetric

Article

MLN4924: a novel first-in-class inhibitor of NEDD8-activating enzyme for cancer therapy

Steffan T Nawrocki, Patrick Griffin, Kevin R Kelly & Jennifer S Carew PhD

Pages: 1563-1573

Published online: 16 Jul 2012

Abstractfor MLN4924: a novel first-in-class inhibitor of NEDD8-activating enzyme for cancer therapy | Full Text | References | PDF (309.9 KB)

1818 Views
141 CrossRef citations
0Altmetric

Article

Olaparib, PARP1 inhibitor in ovarian cancer

Claudia Marchetti MD PhD, Ludovica Imperiale MD, Maria Luisa Gasparri MD, Innocenza Palaia MD, PhD, Sandro Pignata MD, Terenzio Boni MD, Filippo Bellati MD, PhD & Pierluigi Benedetti Panici MD

Pages: 1575-1584

Published online: 13 Jul 2012

Abstractfor Olaparib, PARP1 inhibitor in ovarian cancer | Full Text | References | PDF (233.7 KB)

1073 Views
27 CrossRef citations
0Altmetric

Key Paper Evaluation

Article

The therapeutic potential of PCSK9 inhibition in primary dyslipidemia, the example from SAR236553/REGN727

McKenney JM, Koren MJ, Kereiakes DJ, Hanotin C, Ferrand AC, Stein EA. Safety and efficacy of a monoclonal antibody to proprotein convertase Subtilisin/Kexin type 9 serine protease, SAR236553/REGN727, in patients with primary hypercholesterolemia receiving ongoing stable atorvastatin therapy. J Am Coll Cardiol 2012. [Epub ahead of print].

Amar M Salam MBBS FRCP (London) FACC

Pages: 1585-1588

Published online: 19 Jul 2012

AbstractforThe therapeutic potential of PCSK9 inhibition in primary dyslipidemia, the example from SAR236553/REGN727 | Full Text | References | PDF (175.4 KB)

409 Views
2 CrossRef citations
0Altmetric

Appendix

Erratum

Page: 1589

Published online: 20 Sep 2012

CitationforErratum | Full Text | References | PDF (28.3 KB)

271 Views
0 CrossRef citations
0Altmetric

Free Access

Retraction

Retraction – Horizon scanning for novel therapeutics for the treatment of prostate cancer

Page: 1591

Published online: 20 Sep 2012

AbstractforRetraction – Horizon scanning for novel therapeutics for the treatment of prostate cancer | PDF (86.5 KB)

297 Views
0 CrossRef citations
0Altmetric

Free Access

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

The role of extracellular vesicles in immune cell exhaustion and resistance to immunotherapy

Ava Aghakhani et al.

Review Article | Published online: 30 May 2024

Plain Language Summary of the PAISLEY study: deucravacitinib as a treatment for people with systemic lupus erythematosus

Eric F. Morand et al.

Plain Language Summary of Publication | Published online: 29 May 2024

Open Access

Inflammation and Huntington’s disease – a neglected therapeutic target?

Sophie E. Field et al.

Review Article | Published online: 29 May 2024

Open Access

Clinical application and potential pluripotent effects of hepatocyte growth factor in spinal cord injury regeneration

Shogo Hashimoto et al.

Review Article | Published online: 29 May 2024

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Investigational Drugs (Vol.21, Iss.10, 2012)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?